Related Experiment Video
Updated: Apr 26, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Notch2 activation is protective against anticancer effects of zerumbone in human breast cancer cells
Anuradha Sehrawat1, Kozue Sakao, Shivendra V Singh
1Department of Pharmacology and Chemical Biology, University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, 5117 Centre Avenue, Pittsburgh, PA, USA.
Abstract:
We showed previously that zerumbone (ZER), a sesquiterpene isolated from subtropical ginger, inhibited in vitro (MCF-7 and MDA-MB-231cells) and in vivo (MDA-MB-231 cells) growth of human breast cancer cells in association with apoptosis induction. Here, we investigated the role of Notch receptors in anticancer effects of ZER (cell migration inhibition and apoptosis induction) using breast cancer cells. Western blotting was performed to determine protein expression changes. Effect of ZER on transcriptional activity of Notch was assessed by luciferase reporter assays. Transfection with small hairpin RNA or small interfering RNA was performed for knockdown of Notch2 or Presenilin-1 protein. Cell migration and apoptosis were quantitated by Boyden chamber assay and flow cytometry, respectively. Exposure of MDA-MB-231, MCF-7, and SUM159 cells to ZER resulted in increased cleavage of Notch2 in each cell line. On the other hand, levels of cleaved Notch1 and Notch4 proteins were decreased following ZER treatment. Increased cleavage of Notch2 in ZER-treated cells was accompanied by induction of Presenilin-1 protein and transcriptional activation of Notch. Inhibition of cell migration as well as apoptosis induction resulting from ZER exposure was significantly augmented by knockdown of Notch2 protein. ZER-mediated cleavage of Notch2 protein in MDA-MB-231 cells was markedly attenuated upon RNA interference of Presenilin-1. Knockdown of Presenilin-1 protein also resulted in escalation of ZER-induced apoptosis. The present study indicates that Notch2 activation by ZER inhibits its proapoptotic and anti-migratory response at least in breast cancer cells.
Insights
Zerumbone (ZER) activates Notch2, inhibiting its anticancer effects in breast cancer cells. This suggests Notch2 signaling plays a key role in ZER
Area of Science:
- Oncology
- Molecular Biology
- Natural Products Chemistry
Background:
- Zerumbone (ZER), a sesquiterpene from ginger, previously demonstrated anticancer properties by inhibiting breast cancer cell growth and inducing apoptosis.
- The role of Notch receptors in ZER's anticancer mechanisms, specifically cell migration and apoptosis, remains to be fully elucidated.
Purpose of the Study:
- To investigate the involvement of Notch receptors in the anticancer effects of zerumbone (ZER) on human breast cancer cells.
- To determine how ZER influences Notch receptor cleavage, activation, and downstream signaling pathways.
- To assess the impact of modulating Notch2 and Presenilin-1 on ZER's anti-migratory and pro-apoptotic activities.
Main Methods:
- Western blotting to analyze protein expression levels of Notch receptors and related proteins.
- Luciferase reporter assays to evaluate the transcriptional activity of Notch signaling.
- RNA interference (siRNA/shRNA) to knockdown Notch2 and Presenilin-1 expression.
- Boyden chamber assays and flow cytometry to quantify cell migration and apoptosis, respectively.
Main Results:
- ZER exposure increased the cleavage of Notch2 while decreasing cleaved Notch1 and Notch4 in breast cancer cell lines (MDA-MB-231, MCF-7, SUM159).
- Notch2 cleavage by ZER correlated with increased Presenilin-1 protein and Notch transcriptional activation.
- Knockdown of Notch2 enhanced ZER's inhibition of cell migration and apoptosis induction.
- Interference with Presenilin-1 attenuated ZER-mediated Notch2 cleavage and amplified ZER-induced apoptosis.
Conclusions:
- ZER activates Notch2 signaling, which paradoxically dampens its own pro-apoptotic and anti-migratory effects in breast cancer cells.
- Notch2 and Presenilin-1 are critical mediators of ZER's impact on breast cancer cell behavior.
- Targeting the Notch2 pathway could potentially enhance the therapeutic efficacy of zerumbone in breast cancer treatment.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Notch Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inhibition of Cdk Activity
The Intrinsic Apoptotic Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes

